Health ministers to help orphan drugsBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6994.1557a (Published 17 June 1995) Cite this as: BMJ 1995;310:1557
The European Union is to try to increase research into, and the development of, medicines to treat rare diseases. Health ministers will look for a union-wide strategy to reduce the financial and administrative hurdles of producing these so called orphan drugs. The decision was taken after forceful prodding by the French government.
In a nine page memorandum to EU governments, the French, who hold the rotating presidency until the end of June, argued that European manufacturers were at a competitive disadvantage compared with firms in the US and Japan, where …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial